Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma

Clinical trial NCT01775631 · COMPLETED

Trial details

NCT number: NCT01775631
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Malignancies

Start date: 2013-03-01
Primary completion: 2016-08-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.